Literature DB >> 22569573

Deficits in emotional learning and memory in an animal model of schizophrenia.

Monica M Bolton1, Chelcie F Heaney, Jonathan J Sabbagh, Andrew S Murtishaw, Christy M Magcalas, Jefferson W Kinney.   

Abstract

Alterations in N-methyl-D-aspartate (NMDA) receptor function have been linked to numerous behavioral deficits and neurochemical alterations. Recent investigations have begun to explore the role of NMDA receptor function on principally inhibitory neurons and their role in network function. One of the prevailing models of schizophrenia proposes a reduction in NMDA receptor function on inhibitory interneurons and the resulting disinhibition may give rise to aspects of the disorder. Studies using NMDA receptor antagonists such as PCP and ketamine have induced schizophrenia-like behavioral deficits in animal model systems as well as changes in inhibitory circuits. The current study investigated whether the administration of a subanesthetic dose of ketamine (8 mg/kg subcutaneously), that disrupts sensorimotor gating, also produces impairments in a Pavlovian emotional learning and memory task. We utilized both standard delay and trace cued and contextual fear conditioning (CCF) paradigms to examine if ketamine produces differential effects when the task is more difficult and relies on connectivity between specific brain regions. Rats administered ketamine displayed no significant deficits in cued or contextual fear following the delay conditioning protocol. However, ketamine did produce a significant impairment in the more difficult trace conditioning protocol. Analyses of tissue from the hippocampus and amygdala indicated that the administration of ketamine produced an alteration in GABA receptor protein levels differentially depending on the task. These data indicate that 8 mg/kg of ketamine impairs learning in the more difficult emotional classical conditioning task and may be related to altered signaling in GABAergic systems.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569573      PMCID: PMC3632713          DOI: 10.1016/j.bbr.2012.04.049

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  105 in total

1.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

2.  The GABAB1b isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons.

Authors:  Enrique Pérez-Garci; Martin Gassmann; Bernhard Bettler; Matthew E Larkum
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

3.  Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats.

Authors:  H Lee; J J Kim
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

4.  Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task.

Authors:  S F Logue; R Paylor; J M Wehner
Journal:  Behav Neurosci       Date:  1997-02       Impact factor: 1.912

Review 5.  Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?

Authors:  André Aleman; René S Kahn
Journal:  Prog Neurobiol       Date:  2005-12-13       Impact factor: 11.685

Review 6.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  Hippocampectomy disrupts trace eye-blink conditioning in rabbits.

Authors:  J R Moyer; R A Deyo; J F Disterhoft
Journal:  Behav Neurosci       Date:  1990-04       Impact factor: 1.912

9.  Functional imaging of emotional memory in bipolar disorder and schizophrenia.

Authors:  Heather C Whalley; James McKirdy; Liana Romaniuk; Jessika Sussmann; Eve C Johnstone; Hong I Wan; Andrew M McIntosh; Stephen M Lawrie; Jeremy Hall
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

10.  An animal model of emotional blunting in schizophrenia.

Authors:  Charmaine Y Pietersen; Fokko J Bosker; Janine Doorduin; Minke E Jongsma; Folkert Postema; Joseph V Haas; Michael P Johnson; Tineke Koch; Tony Vladusich; Johan A den Boer
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  15 in total

1.  Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Authors:  Philip L R Gaskin; Stephen P H Alexander; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

2.  Neogenin in Amygdala for Neuronal Activity and Information Processing.

Authors:  Xiang-Dong Sun; Wen-Bing Chen; Dong Sun; Jie Huang; Yuan-Quan Li; Jin-Xiu Pan; Ya-Nan Wang; Kai Zhao; Zhao-Qi Dong; Hong-Sheng Wang; Lei Xiong; Aiguo Xuan; Shen-Ting Zhao; Anilkumar Pillai; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2018-09-18       Impact factor: 6.167

3.  Testing synaptic plasticity in dynamic mate choice decisions: N-methyl D-aspartate receptor blockade disrupts female preference.

Authors:  Mary E Ramsey; Wendy Vu; Molly E Cummings
Journal:  Proc Biol Sci       Date:  2014-05-07       Impact factor: 5.349

4.  Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats.

Authors:  Jonathan J Sabbagh; Andrew S Murtishaw; Monica M Bolton; Chelcie F Heaney; Michael Langhardt; Jefferson W Kinney
Journal:  Neurosci Lett       Date:  2013-07-01       Impact factor: 3.046

5.  Baclofen administration alters fear extinction and GABAergic protein levels.

Authors:  Chelcie F Heaney; Monica M Bolton; Andrew S Murtishaw; Jonathan J Sabbagh; Christy M Magcalas; Jefferson W Kinney
Journal:  Neurobiol Learn Mem       Date:  2012-09-23       Impact factor: 2.877

Review 6.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

Review 7.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

8.  Increased hippocampal CA1 cerebral blood volume in schizophrenia.

Authors:  Pratik Talati; Swati Rane; Samet Kose; Jennifer Urbano Blackford; John Gore; Manus J Donahue; Stephan Heckers
Journal:  Neuroimage Clin       Date:  2014-07-22       Impact factor: 4.881

9.  The effect of ketamine on the consolidation and extinction of contextual fear memory.

Authors:  Nicholas E Clifton; Kerrie L Thomas; Jeremy Hall
Journal:  J Psychopharmacol       Date:  2018-01-17       Impact factor: 4.153

10.  Cannabinoid modulation of functional connectivity within regions processing attentional salience.

Authors:  Sagnik Bhattacharyya; Irina Falkenberg; Rocio Martin-Santos; Zerrin Atakan; Jose A Crippa; Vincent Giampietro; Mick Brammer; Philip McGuire
Journal:  Neuropsychopharmacology       Date:  2014-09-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.